Who Controls Mifepristone? The Politics Blocking a New Era of Contraception

PUBLISHED 1/22/2026 by

Mifepristone “works against endometriosis. It works against myoma [fibroids]. We are now involved in a study group that looks at whether it can prevent breast cancer,” says pioneering reproductive-health advocate Dr. Rebecca Gomperts. “It has so many potential uses, and it hasn’t been [developed].

“If we as women don’t make sure that it becomes available to meet our needs … then it won’t happen.”

This is the final installment of a new series, “The Moral Property of Women: How Antiabortion Politics Are Withholding Medical Care,” a serialized version of the Winter 2026 print feature article.

Mifepristone Could Treat Endometriosis, Some Cancers, Depression and Chronic Illness—If Politics Didn’t Interfere

PUBLISHED 1/21/2026 by

Across a range of conditions that disproportionately affect women, research into mifepristone’s potential has been slowed, defunded or blocked altogether. Nowhere is that clearer than in the treatment of endometriosis and other serious illnesses that leave millions of women in chronic pain.

Endometriosis—when endometrium cells grow outside the uterus—afflicts an estimated 10 percent of reproductive-age women. It can lead to chronic pelvic and back pain, heavy or abnormal bleeding, pain during sex or bowel movements, fatigue, bloating, digestive issues, infertility, anxiety and depression.

Mifepristone can help—it blocks the progesterone causing the cellular growth and decreases the size of existing endometrial lesions, thereby relieving painful symptoms. But antiabortion politics have obstructed the development of the medication for these uses in the U.S.

Researchers have also produced studies showing mifepristone is effective for treating ovarian and breast cancer, chronic inflammatory diseases, and several psychiatric disorders, including major depressive disorder, post-traumatic stress disorder (PTSD) and psychotic depression.

This is Part 2 of 3 in a new series, “The Moral Property of Women: How Antiabortion Politics Are Withholding Medical Care,” a serialized version of the Winter 2026 print feature article.

‘The Moral Property of Women’: Mifepristone, Fibroids and the Stakes of Suppressed Science

PUBLISHED 1/20/2026 by

Despite mifepristone’s broad medical promise, its development has been repeatedly stymied by abortion opponents who fear wider availability would weaken their attempts to suppress abortion access.

More than 26 million women in the U.S. are affected by fibroids, which are noncancerous growths of the uterus that can reach the size of a grapefruit or larger. Treatment too often defaults to invasive surgery, either removing the fibroids or performing hysterectomies.

In China today, a three-month regimen of 10 milligrams of mifepristone per day is the approved protocol for treating fibroids. Meanwhile, American women still do not have access to this very effective nonsurgical treatment.

This is Part 1 of 3 in a new series, “The Moral Property of Women: How Antiabortion Politics Are Withholding Medical Care,” a serialized version of the Winter 2026 print feature article.

‘We’re 53 Years Ahead of Where They Were Then’: Looking Back at 50+ Years of Ms.—and Looking Forward to a Feminist Future

PUBLISHED 12/29/2025 by

In a new bonus episode of Looking Back, Moving Forward, Ms. executive editor Kathy Spillar, consulting editor Carmen Rios, Ms. Committee of Scholars co-chair Janell Jobson, and legendary author, activist and professor Loretta Ross explore how the stories of our past can continue to inspire us—and give us hope in the fight forward.

“I don’t believe that the assault on women and women’s rights can be extracted from the overall dysfunction of all societies.”

“We have to keep rewriting history and reclaiming history, especially knowing that the forces out there are doing what they can to erase us.”

“There’s a long lineage of people who have been fighting this fight, because they know that we deserve justice.”

Sneak Peek: What’s in the Winter Issue of Ms.? Groundbreaking Reporting on Women’s Health and Power

PUBLISHED 12/26/2025 by

Mifepristone has shown potential to treat a striking range of diseases and conditions, some life-threatening: fibroids, breast cancer, depression, endometriosis, Gulf War illness and maybe even other autoimmune diseases, such as chronic fatigue syndrome and multiple sclerosis. Research also suggests that mifepristone may help prevent some forms of breast cancer and can serve as an effective weekly contraceptive without the side effects of hormonal birth control.

Yet despite the drug’s promise, its development has been repeatedly stymied by abortion opponents who fear wider availability would weaken their attempts to suppress abortion access. 

The result? Women are left in needless pain and subject to invasive and unnecessary surgical procedures like hysterectomies.

My Daughter Was in the Mass Shooting at Brown, and I Wasn’t Trained for What to Do

PUBLISHED 12/16/2025 by

The text, from a fellow ER doctor and former Brown University faculty member, arrived at 4:27 p.m. on Saturday: “Active shooter near Brown engineering building? Is Hannah ok?” Within seconds, I looked on my phone for my daughter’s location—she was on campus in Friedman Hall. I texted her. It was real. There was an active shooter. She was hiding in a bathroom with her four best friends. For the next 24 hours, I lived every parent’s nightmare while learning hard lessons about a reality even I was not trained for.

As an emergency medicine physician with over 20 years of experience, I’ve operated from positions of information and authority in mass casualties before. This weekend, I had neither. I was simply a mother trying to keep my daughter safe from 150 miles away, armed only with a phone and whatever guidance I could piece together. I want to share what I learned, because on Saturday, thousands of students were in lockdown texting their anxious parents, and I realized how unprepared we are for this side of the experience.

‘Ms. Does Not Flinch’: Why Independent Feminist Journalism Matters

PUBLISHED 12/11/2025 by

Bonnie Thornton Dill on the enduring power of Ms. magazine:

“Opening minds and eyes is what Ms. is about, and there has been no time when Ms. is more needed than it is today. …

“While major media outlets rarely, if ever, report on violence to abortion clinics and abortion providers … Ms. keeps a constant tab and a laser focus on that sort of violence, including how the deadly violence that targeted lawmakers in Minnesota was the result of antiabortion extremism. …

And what national media outlet is tracking the administration’s attacks on women and gender studies programs?”

For Women Spending the Holidays in Prison or a Shelter, You Can Make a Difference

PUBLISHED 12/8/2025 by

Women and girls are the fastest growing incarcerated population in the United States today. The women now in prison are often there because of circumstances that might have put you or me there, too. 

We at Ms. magazine want women in prison to know they are seen and valued. And because domestic violence shelters can be almost as isolating as prisons—and often lack reading material, just as many prisons do—we want to support women in those shelters, too. 

For a tax-deductible donation of just $30, you can help send Ms. to a woman in prison or a domestic violence shelter for a year. And for just $10 more ($40 total), you can get a year’s worth of Ms. for yourself as well.